MHRA announces consultation on improved safety for high risk in vitro diagnostic devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (21 May 2024) launched a four-week consultation which will support improved safety for certain high risk in vitro diagnostic (IVD) devices.
Read the press release from Medicines and Healthcare products Regulatory Agency published on 21 May 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (5 juillet 2024). MHRA announces consultation on improved safety for high risk in vitro diagnostic devices. ELSIBI. Consulté le 19 janvier 2025 à l’adresse https://doi.org/10.58079/11yb4
